News

Filter

Current filters:

None

8826 to 8835 of 96601 results

Pfizer tops social media presence ranking

19-12-2011

Cegedim Strategic Data (CSD), a provider of integrated health care market research and worldwide promotional…

Markets & MarketingMerck & CoNovartisPfizerPharmaceutical

Plant molecular farming: a new Biotech Wave

19-12-2011

Currently, the two approved methods of biopharmaceuticals manufacturing widely used in Europe are mammalian…

BASFBayerBiotechnologyPharmaceuticalResearch

COPD market to grow to more than $13.4 billion in 2020

19-12-2011

As a result of an expanding aging population, increases in drug treatment and the uptake of premium priced…

Boehringer IngelheimGlobalMarkets & MarketingolodaterolPharmaceuticalRespiratory and Pulmonarytiotropium

EMA recommends approval of Roche’s Zelboraf

19-12-2011

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended…

Daiichi SankyoEuropeOncologyPharmaceuticalRegulationRocheZelboraf

Gilead filing of Truvada for PrEP looks contentious

19-12-2011

US biotech firm Gilead Sciences’ (Nasdaq: GILD) decision last week to submit a supplemental New…

Anti-viralsBiotechnologyGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Takeda to drop peginesatide commercialization in Japan

19-12-2011

Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502) has decided not to commercialize peginesatide…

AffymaxAsia-PacificLicensingNephrology and HepatologypeginesatidePharmaceuticalTakeda Pharmaceuticals

Musical chairs at Amgen and Roche

19-12-2011

USA-based Amgen (Nasdaq: AMGN), the world’s largest independent biotech company, says that Kevin…

AmgenBiotechnologyManagementPharmaceuticalRoche

Germany’s IQWIG negative on InterMune’s Esbriet

18-12-2011

US biotech firm InterMune (Nasdaq: ITMN) says that Germany’s private Institute for Quality and Efficiency…

BiotechnologyEsbrietEuropeInterMuneRare diseasesRegulationRespiratory and Pulmonary

8826 to 8835 of 96601 results

Back to top